CG Oncology, Inc.
For the period ended Dec 31, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 28, 2025
CGON$74.74-1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
EXHIBIT INDEX
| ExhibitNumber · Exhibit Description · Incorporated by Reference · FiledHerewith | |||||
|---|---|---|---|---|---|
| Form · Date · Number | |||||
| 3.1 | Amended and Restated Certificate of Incorporation | S-1/A | 01/18/24 | 3.3 | |
| 3.2 | Amended and Restated Bylaws | S-1 | 01/02/24 | 3.4 | |
| 4.1 | Specimen stock certificate evidencing the shares of common stock | S-1/A | 01/18/24 | 4.1 | |
| 4.2 | Amended and Restated Investors’ Rights Agreement, dated July 28, 2023, as amended, by and among the Registrant and certain of its stockholders | S-1/A | 01/18/24 | 4.2 | |
| 4.3 | Description of Registered Securities | 10-K | 03/26/24 | 4.3 | |
| 10.1# | CG Oncology, Inc. 2015 Equity Incentive Plan, as amended, and form of stock grant agreement and form of stock option agreement thereunder | S-8 | 01/26/24 | 10.1 | |
| 10.2# | CG Oncology, Inc. 2022 Incentive Award Plan and form of stock option agreement, form of stock option agreement (early exercise) and form of restricted stock unit agreement thereunder | S-8 | 01/26/24 | 10.2 | |
| 10.3# | CG Oncology, Inc. 2024 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunder | S-8 | 01/26/24 | 10.3 | |
| 10.4# | CG Oncology, Inc. 2024 Employee Stock Purchase Plan | S-8 | 01/26/24 | 10.4 | |
| 10.5# | Amended and Restated Non-Employee Director Compensation Program | X | |||
| 10.6† | Development and License Agreement, dated March 11, 2019, between the Lepu Biotech Co., Ltd. and the Registrant | S-1 | 01/02/24 | 10.6 | |
| 10.7† | License and Collaboration Agreement, dated March 26, 2020, between Kissei Pharmaceutical Co., Ltd. and the Registrant | S-1 | 01/02/24 | 10.7 | |
| 10.8† | First Amendment to the License and Collaboration Agreement, dated September 15, 2022, between Kissei Pharmaceutical Co., Ltd. and the Registrant | S-1 | 01/02/24 | 10.8 | |
| 10.9# | Form of Indemnification Agreement for Directors and Officers | S-1 | 01/02/24 | 10.9 | |
| 10.10# | Annual Bonus Plan | S-1 | 01/02/24 | 10.11 | |
| 10.11# | Amended and Restated Employment Agreement, effective January 9, 2025, between Arthur Kuan and the Registrant | X | |||
| 10.12# | Amended and Restated Employment Agreement, effective January 9, 2025, between Ambaw Bellete and the Registrant | X | |||
| 10.13# | Amended and Restated Employment Agreement, effective January 9, 2025, between Vijay Kasturi and the Registrant | X | |||
| 10.14# | Amended and Restated Employment Agreement, effective January 9, 2025, between Corleen Roche and the Registrant | X | |||
| 10.15# · Amended and Restated Employment Agreement, effective January 9, 2025, between Joshua F. Patterson and the Registrant · X | |||||
|---|---|---|---|---|---|
| 19.1 · Insider Trading Policy · X | |||||
| 21.1 · Subsidiaries of the Registrant · X | |||||
| 23.1 · Consent of Independent Registered Public Accounting Firm · X | |||||
| 24.1 · Power of Attorney (see signature page) · X | |||||
| 31.1 · Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 31.2 · Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 32.1* · Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 32.2* · Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 · X | |||||
| 97# | Policy for the Recovery of Erroneously Awarded Compensation | S-1 | 01/02/24 | 10.10 | |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Document. | X | |||
| 104 | Cover page formatted as Inline XBRL and contained in Exhibit 101 | X | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.